Delayed
Toronto S.E.
08:10:33 20/06/2024 pm IST
|
5-day change
|
1st Jan Change
|
8.1
CAD
|
-0.25%
|
|
+1.62%
|
+16.95%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
2,716
|
1,656
|
1,311
|
1,534
|
-
|
Enterprise Value (EV)
1 |
3,728
|
2,605
|
2,319
|
2,532
|
2,525
|
P/E ratio
|
-13.3
x
|
-98.9
x
|
-15.1
x
|
-33.3
x
|
-102
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.63
x
|
1.32
x
|
0.92
x
|
0.99
x
|
0.9
x
|
EV / Revenue
|
3.62
x
|
2.08
x
|
1.63
x
|
1.64
x
|
1.48
x
|
EV / EBITDA
|
19.4
x
|
11.3
x
|
8.93
x
|
8.92
x
|
7.94
x
|
EV / FCF
|
92
x
|
28.8
x
|
18.3
x
|
17.8
x
|
14.8
x
|
FCF Yield
|
1.09%
|
3.47%
|
5.47%
|
5.62%
|
6.74%
|
Price to Book
|
1.81
x
|
0.93
x
|
0.75
x
|
0.89
x
|
0.9
x
|
Nbr of stocks (in thousands)
|
1,66,911
|
1,86,034
|
1,88,413
|
1,88,952
|
-
|
Reference price
2 |
16.27
|
8.900
|
6.960
|
8.120
|
8.120
|
Announcement Date
|
25/03/22
|
23/03/23
|
22/03/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
1,031
|
1,250
|
1,426
|
1,545
|
1,711
|
EBITDA
1 |
-
|
191.8
|
230.6
|
259.7
|
283.8
|
318.2
|
EBIT
1 |
-
|
-81.5
|
40.3
|
56.6
|
133.7
|
158.5
|
Operating Margin
|
-
|
-7.91%
|
3.22%
|
3.97%
|
8.65%
|
9.26%
|
Earnings before Tax (EBT)
1 |
-
|
-171.2
|
-77.4
|
-102.5
|
-21
|
19
|
Net income
1 |
-169.2
|
-160.4
|
-16.6
|
-85.6
|
-25.51
|
-8.481
|
Net margin
|
-
|
-15.56%
|
-1.33%
|
-6%
|
-1.65%
|
-0.5%
|
EPS
2 |
-1.890
|
-1.220
|
-0.0900
|
-0.4600
|
-0.2437
|
-0.0799
|
Free Cash Flow
1 |
-
|
40.5
|
90.4
|
126.9
|
142.4
|
170.1
|
FCF margin
|
-
|
3.93%
|
7.23%
|
8.9%
|
9.22%
|
9.94%
|
FCF Conversion (EBITDA)
|
-
|
21.12%
|
39.2%
|
48.86%
|
50.16%
|
53.45%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/04/21
|
25/03/22
|
23/03/23
|
22/03/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
272.5
|
280.2
|
327
|
312.1
|
331
|
358.3
|
368.3
|
336.9
|
362.2
|
372.4
|
395.7
|
374.2
|
403.1
|
413.2
|
418.4
|
EBITDA
1 |
50.1
|
50.1
|
59.8
|
59.3
|
60.6
|
65.6
|
67
|
60.9
|
65.8
|
68.1
|
72.36
|
68.63
|
74.84
|
76.82
|
79.4
|
EBIT
1 |
-16.37
|
8.6
|
11.8
|
9.6
|
9.5
|
5.8
|
16.5
|
10.7
|
15.1
|
17.3
|
34.57
|
31.47
|
37.16
|
-
|
-
|
Operating Margin
|
-6.01%
|
3.07%
|
3.61%
|
3.08%
|
2.87%
|
1.62%
|
4.48%
|
3.18%
|
4.17%
|
4.65%
|
8.74%
|
8.41%
|
9.22%
|
-
|
-
|
Earnings before Tax (EBT)
|
-42
|
-24.5
|
-2.8
|
-16.9
|
-33.3
|
-
|
-
|
-12.6
|
-43.1
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-43.1
|
-11
|
2.4
|
-14.7
|
6.6
|
-33.3
|
-7.3
|
-9.8
|
-35.1
|
-11.7
|
-7.006
|
-11.75
|
-9.525
|
-
|
-
|
Net margin
|
-15.82%
|
-3.93%
|
0.73%
|
-4.71%
|
1.99%
|
-9.29%
|
-1.98%
|
-2.91%
|
-9.69%
|
-3.14%
|
-1.77%
|
-3.14%
|
-2.36%
|
-
|
-
|
EPS
2 |
-0.2400
|
-0.0600
|
0.0100
|
-0.0800
|
0.0400
|
-0.1800
|
-0.0400
|
-0.0500
|
-0.1900
|
-
|
-0.0442
|
-0.0429
|
-0.0421
|
-0.0360
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/03/22
|
10/05/22
|
12/08/22
|
09/11/22
|
23/03/23
|
12/05/23
|
04/08/23
|
08/11/23
|
22/03/24
|
10/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
1,012
|
950
|
1,008
|
997
|
991
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
5.276
x
|
4.118
x
|
3.88
x
|
3.514
x
|
3.114
x
|
Free Cash Flow
1 |
-
|
40.5
|
90.4
|
127
|
142
|
170
|
ROE (net income / shareholders' equity)
|
-
|
5.68%
|
7.11%
|
3.76%
|
5.36%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
9.000
|
9.590
|
9.220
|
9.080
|
9.020
|
Cash Flow per Share
2 |
-
|
0.4200
|
0.7600
|
0.8200
|
1.010
|
1.080
|
Capex
1 |
-
|
14.6
|
23.9
|
26.5
|
31
|
29.1
|
Capex / Sales
|
-
|
1.42%
|
1.91%
|
1.86%
|
2.01%
|
1.7%
|
Announcement Date
|
30/04/21
|
25/03/22
|
23/03/23
|
22/03/24
|
-
|
-
|
Last Close Price
8.12
CAD Average target price
10.04
CAD Spread / Average Target +23.58% Consensus |
1st Jan change
|
Capi.
|
---|
| +16.95% | 1.12B | | +24.94% | 89.22B | | -22.45% | 76.59B | | +3.24% | 26.87B | | -8.86% | 17.41B | | +0.78% | 17.25B | | -0.18% | 15.25B | | +81.32% | 13.43B | | +73.75% | 13.26B | | -24.74% | 13.22B |
Other Healthcare Facilities & Services
|